The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): -
Expected first date of trading: 22/05/2002
Market: AIM
Location of address at which admission document will be available: KBC Peel Hunt Ltd 62 Threadneedle Street London EC2R 8HP
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): KBC Peel Hunt Ltd
Nominated Broker (AIM Companies): KBC Peel Hunt Ltd
Financial PR Advisors: -

Company details
Name Role
Lord Norman Roy Blackwell Non Executive Chairman of the Board
Dr Raymond Francis Akers Chief Executive Officer and Director
Paul Bertram Freedman Chief Financial Officer and Director
Daniel Lamont Seckinger Director of Clinical Research and Director
Edward Andrew Mulhare Non Executive Director
Edward L Wampold Non Executive Director
David Wilbraham Non Executive Director

Facts and Figures
Fiscal year end: - -
Incorporated in: United States of America
Website URL: http://
space
Description of business:
Developer and manufacturer of rapid, point of care diagnostic screening and testing products.

Person(s) interested:
Milan Holding Company Inc 11.35% Dolores Akers 6.91% DMI Investments BV 6.80%


Akers Biosciences Inc.

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds